Biomarker test a boon for uveal melanoma diagnosis

Australian study demonstrates high sensitivity and specificity

Doctors could soon be using a blood test as a minimally invasive monitoring tool for the early detection of uveal melanoma, Australian researchers say.


A team from the University of Queensland (UQ) has found a panel of six blood biomarkers that can differentiate uveal benign moles and melanomas, as well as whether the melanomas have metastasised.

Their cross-sectional study measured the levels of 17 microRNA biomarkers in the blood samples of 10 patients with choroidal naevi, 50 patients with localised uveal melanoma and five patients with